Company

Siphox, Inc.

Siphox develops at-home blood testing kits using silicon photonic biosensors.

About

Siphox provides at-home testing kits that use silicon photonics to measure blood biomarkers related to inflammation, hormones, metabolism and cardiovascular health. Its kit is designed to deliver lab-quality results from a small blood sample. Founded in 2020 and based in Massachusetts, the company raised USD 10 million in seed funding in July 2023, led by Khosla Ventures and Y Combinator, with participation from CEP America, LLC, Longevity Tech Fund, M2I2, Metaplanet Holdings and Rsquared.

2Funding rounds

11Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in